Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know

Core Viewpoint - Adaptive Biotechnologies (ADPT) has shown a significant price increase of 20.3% over the past four weeks, with a mean price target of $7.33 indicating a potential upside of 31.4$5.58 [1] Price Target Analysis - The average price target consists of six estimates ranging from a low of $5 to a high of$10, with a standard deviation of $1.63, indicating variability among analysts [2] - The lowest estimate suggests a decline of 10.4%, while the highest points to a potential upside of 79.2% [2] - A low standard deviation indicates a higher agreement among analysts regarding the stock's price movement [7] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about ADPT's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which correlates with potential stock price increases [4][9] - The Zacks Consensus Estimate for the current year has risen by 6.1% over the past month, with two estimates increasing and no negative revisions [10] Zacks Rank and Investment Potential - ADPT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [11]